AdAPT-001

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameAdAPT-001
Drug Alias NameAdAPT-001
ClassificationBiologics > Oncolytic virusCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionCell death stimulantsImmunostimulantsTransforming growth factor beta inhibitors
TargetsTransforming growth factor beta
Therapy Area/IndicationsSolid tumoursSarcomaChondrosarcoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEpicentrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpicentrx Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursSarcomaChondrosarcoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A